Literature DB >> 622829

e-Antigen and anti-e in two categories of chronic carriers of hepatitis B surface antigen.

A M Couroucé-Pauty, A Plançon.   

Abstract

Screening for e antigen and anti-e was performed in 517 HBs antigen chronic carriers, 329 blood donors and 188 hemodialyzed patients. e antigen was detected in 35 blood donors (10.6 percent): 88 percent had a high titre of HBsAg, and 80 percent had a distrubed liver function. No difference was noted regarding sex and age of the carrier. Anti-e was detected in 33.7 percent of the bood donors. A significant difference (p less than 0.01) was noted between males (29 percent) and females (46.6 percent). Anti-e was found more prevalent in young people between 21 and 34 than in older people (p less than 0.05). Anti-e was rarely found when the titre of HBsAg was low or high. 88 percent of the anti-e carriers had an intermediate titre from 1/1 to 1/32 by CEP. Both e Ag and anti-e were more prevalent in ad subtype than in ay subtype (p less than 0.02 for both). Inside the ad subtype, anti-e is less frequent in adr (6 percent) than in adw2 (42 percent) and in adw4 (57 percent); p less than 0.01. The difference between the prevalence of e Ag in adr (31 percent) and in adw2 (17 percent) is not significant but the healthy carriers with e antigen are more numerous in adr than in adw2 subtype. e antigen was detected in 53.7 percent of HBs Ag-hemodialyzed patients and anti-e in 3.7 percent of these patients. These results are neither correlated with the liver function nor with the state of chronic carrier (27 percent of e Ag in transient HBs Ag carrier).

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 622829     DOI: 10.1111/j.1423-0410.1978.tb02473.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  7 in total

1.  Third component, HBeAg/3, of hepatitis B e antigen system, identified by three different double-diffusion techniques.

Authors:  B Murphy; E Tabor; V McAuliffe; A Williams; J Maynard; R Gerety; R Purcell
Journal:  J Clin Microbiol       Date:  1978-09       Impact factor: 5.948

2.  Hepatitis B infection in institutionalized Down's syndrome inmates: a longitudinal study with five hepatitis B virus markers.

Authors:  R A Hawkes; C R Boughton; D R Schroeter; R H Decker; L R Overby
Journal:  Clin Exp Immunol       Date:  1980-06       Impact factor: 4.330

3.  Prevalence of hepatitis B markers in Indochinese refugees.

Authors:  R K Chaudhary; E S Nicholls; D A Kennedy
Journal:  Can Med Assoc J       Date:  1981-12-01       Impact factor: 8.262

4.  Quantitation of HBeAG and anti-HBe by RIA in sera of chronic HBsAG carriers and individuals with type B hepatitis.

Authors:  W Arnold; G Hess; H Kawakami; K H Meyer zum Büschenfelde
Journal:  Klin Wochenschr       Date:  1981-06-15

5.  Significance of tests for HBeAg and anti-HBe in HBsAg positive blood donors.

Authors:  B C Dow; I Macvarish; A Barr; R J Crawford; R Mitchell
Journal:  J Clin Pathol       Date:  1980-11       Impact factor: 3.411

6.  Detection of HBe antigen in sera from HBs antigen asymptomatic carrier and hepatitis patients using polyethylene glycol (PEG).

Authors:  T Tsuji; T Okada; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1979

7.  Hepatitis Be antigen and antibody in hepatitis B surface antigen positive blood donors.

Authors:  A Barr; S H Black; C J Burrell; B Dow; I Macvarish
Journal:  J Clin Pathol       Date:  1979-02       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.